Ni Shu - China Health Head Department
| CNHC Stock | USD 0.01 0.0006 10.91% |
Insider
Ni Shu is Head Department of China Health Management
| Phone | 214-691-0055 |
| Web | https://www.chinahealthcorp.com |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Starkey | Boxlight Corp Class | 51 | |
| Matt Hunt | Boxlight Corp Class | N/A | |
| Jason DePue | Siyata Mobile | N/A | |
| Charles MBA | Barloworld Ltd ADR | 66 | |
| Christopher Wierenga | Barloworld Ltd ADR | 46 | |
| Emmanuel BSc | Barloworld Ltd ADR | 54 | |
| Andy Pennington | Boxlight Corp Class | N/A | |
| Gregory Wiggins | Boxlight Corp Class | 44 | |
| CPA CPA | Boxlight Corp Class | 43 | |
| Eyal Pressler | Siyata Mobile | N/A | |
| PDBA Bcom | Barloworld Ltd ADR | 50 | |
| Dominic BSc | Barloworld Ltd ADR | 57 | |
| Gerald Bernstein | Siyata Mobile | 61 | |
| Tantaswa Fubu | Barloworld Ltd ADR | 50 | |
| Lex Knol | Barloworld Ltd ADR | 68 | |
| Derek Graham | ClearOne | 55 | |
| Litha Nkombisa | Barloworld Ltd ADR | 56 | |
| HDip CA | Barloworld Ltd ADR | 54 | |
China Health Management Leadership Team
Elected by the shareholders, the China Health's board of directors comprises two types of representatives: China Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Health's management team and ensure that shareholders' interests are well served. China Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rui Qu, Department Head of Physical Examination Department | ||
| Charles Chen, Chief Medical Officer of Medical Department | ||
| Xu Mei, CEO and President and Director | ||
| Ni Shu, Head Department | ||
| Liang Xu, Head of Fin. and Accounting and Admin. Director |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Profit Margin | (0.24) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 17.53 M | |||
| Shares Outstanding | 81.15 M | |||
| Price To Earning | (1.80) X | |||
| Price To Sales | 3.18 X | |||
| Revenue | 542.38 K | |||
| Gross Profit | 108.47 K | |||
| Net Income | (129.28 K) | |||
| Current Ratio | 1.09 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.